Rialto Wealth Management, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 2054966
SYRACUSE, NY
Position in ESPR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
593
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rialto Wealth Management, LLC holds $40,087 across 16 Drug Manufacturers - Specialty & Generic names. ESPR ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,174 | $9,152 | |
| 2 | VTRS |
Viatris Inc
|
537 | $8,527 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9 | $4,876 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
164 | $4,036 | |
| 5 | CRON |
Cronos Group Inc.
|
1,000 | $2,780 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
16 | $2,696 | |
| 7 | ZTS |
Zoetis Inc.
|
33 | $2,371 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
133 | $2,302 |
All Filings in ESPR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 593 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | — | 593 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | — | 593 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | — | 593 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | — | 593 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | — | 296 | Shares | Sole | 2025-04-10 | |
| No filing history on record for this holder in this stock. | ||||||